4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-25-004942
CVP, Chief Financial Officer sold 11,250 shares at $74.40 ($837,035)
- CVP, Chief Financial Officer acquired 11,250 shares (option exercise)
- CVP, Chief Financial Officer gave up 1,406 shares (to pay taxes)
- CVP, Chief Financial Officer acquired 13,400 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ullem Scott B. · CVP, Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-07 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −1,406 | $74.92 | $105,338 | 27,698 | D |
| 2025-05-08 | Grant or award : show line 2 in the form 10b5-1 | +13,400 | 41,098 | D | ||
| 2025-05-09 | Exercise or conversion : show line 3 in the form 10b5-1 | +11,250 | $45.28 | $509,363 | 52,348 | D |
| 2025-05-09 | Sale : show line 4 in the form 10b5-1 | −11,250 | $74.40 | $837,035 | 41,098 | D |
| Open-market sales · 11,250 sh · avg $74.40 · $837,035 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-08 | Grant or award : show line 5 in the form 10b5-1 Employee Stock Option (Right to Acquire) | +75,200 | 75,200 | D |
| 2025-05-08 | Grant or award : show line 6 in the form 10b5-1 Performance Rights | +13,400 | 13,400 | D |
| 2025-05-09 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −11,250 | 0 | D |
Loading xslF345X05/doc4.xml…